Gene: MAPK8IP1
Official Full Name: mitogen-activated protein kinase 8 interacting protein 1provided by HGNC
Gene Summary: This gene encodes a regulator of the pancreatic beta-cell function. It is highly similar to JIP-1, a mouse protein known to be a regulator of c-Jun amino-terminal kinase (Mapk8). This protein has been shown to prevent MAPK8 mediated activation of transcription factors, and to decrease IL-1 beta and MAP kinase kinase 1 (MEKK1) induced apoptosis in pancreatic beta cells. This protein also functions as a DNA-binding transactivator of the glucose transporter GLUT2. RE1-silencing transcription factor (REST) is reported to repress the expression of this gene in insulin-secreting beta cells. This gene is found to be mutated in a type 2 diabetes family, and thus is thought to be a susceptibility gene for type 2 diabetes. [provided by RefSeq, May 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10642 | MAPK8IP1 Knockout cell line (HeLa) | Human | MAPK8IP1 | 1:3~1:6 | Negative | Online Inquiry |
KO10643 | MAPK8IP1 Knockout cell line (HCT 116) | Human | MAPK8IP1 | 1:2~1:4 | Negative | Online Inquiry |
KO10644 | MAPK8IP1 Knockout cell line (HEK293) | Human | MAPK8IP1 | 1:3~1:6 | Negative | Online Inquiry |
KO10645 | MAPK8IP1 Knockout cell line (A549) | Human | MAPK8IP1 | 1:3~1:4 | Negative | Online Inquiry |
MAPK8IP1 Gene Knockout Cell Lines are engineered cellular models designed to investigate the functional role of the MAPK8IP1 gene in various biological processes. This gene, also known as JIP1, plays a pivotal role in modulating the JNK (c-Jun N-terminal kinase) signaling pathway, which is crucial for cell proliferation, differentiation, and apoptosis. By employing CRISPR-Cas9 gene-editing technology, these knockout cell lines selectively disrupt MAPK8IP1 expression, enabling researchers to analyze the resultant phenotypic changes and elucidate the gene's specific contributions within the cellular context.
The primary function of MAPK8IP1 involves acting as a scaffolding protein that facilitates the assembly of signaling complexes, thus ensuring the precise activation and regulation of the JNK pathway. The disruption of this gene can lead to aberrant signaling cascades, making knockout cell lines invaluable tools for studying cellular responses to stress, inflammation, and oncogenic signaling. In research and clinical settings, these models can provide significant insights into diseases where JNK signaling is implicated, including cancer, neurodegenerative disorders, and metabolic syndromes.
One of the key advantages of MAPK8IP1 Gene Knockout Cell Lines is their specificity and reproducibility in targeting the gene of interest, which surpasses traditional methods such as RNA interference that may have off-target effects. This enhances the reliability of experimental observations, enabling more straightforward interpretation and application in both basic and applied research contexts.
Our MAPK8IP1 Gene Knockout Cell Lines stand out due to their comprehensive characterization and validation, ensuring researchers have access to high-quality, reliable models. The value of these cell lines is underscored by the growing demand for precise genetic tools that can aid in the exploration of complex biological pathways, thus fostering innovative therapeutic strategies.
As a company committed to advancing biological discoveries, we combine cutting-edge experimental techniques with a deep understanding of molecular biology, providing researchers and clinicians with high-caliber products that support their quest for knowledge in the increasingly complex landscape of gene function and regulation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.